Skip to main content
Clinical Trials/KCT0000951
KCT0000951
Recruiting
未知

Dexmedetomidine-ketamine and Dexmedetomidine-Midazolam-Fentanyl combinations for sedation in chemoport insertion procedure: a randomized prospective study

Ewha Womans University Medical Center0 sites56 target enrollmentTBD
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Ewha Womans University Medical Center
Enrollment
56
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) 18\-65 age
  • 2\) ASA (American society of anesthesiologists)class I\-II
  • 3\) Patients undergoing chemoport insertion procedure in the Ewha womans university mokdong hospital

Exclusion Criteria

  • 1\) Contraindication to dexmedetomidine, Ketamine, Midazolam, Fentanyl
  • 2\) underlying psychologic disorder
  • 3\) \> ASA class 3
  • 4\) decreased renal, hepatic function
  • 5\) respiratory disease, sleep apnea, airway obstructive disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials